Foreword

Kidney Disease: Improving Global Outcomes invited Sharon Moe, MD, and Tilman Drueke, MD, to co-chair a Work Group to develop a chronic kidney disease –MBD guideline

Kai-Uwe Eckardt

2009

Scholarcy highlights

  • Kidney Disease: Improving Global Outcomes invited Sharon Moe, MD, and Tilman Drueke, MD, to co-chair a Work Group to develop a chronic kidney disease–MBD guideline
  • Professional societies throughout the world have decided that there is a need for developing clinical practice guidelines for patients with chronic kidney disease
  • Along with this perceived need has come the realization that developing high-quality guidelines requires substantial resources and expertise
  • During the development of the CKD–MBD guideline, KDIGO continued to develop a system for rating the strength of recommendations and the overall quality of evidence supporting those recommendations
  • The lack of ‘A’ and ‘B’ grades of overall quality of evidence is a result of the lack of patient-centered outcomes as end points in the majority of trials in this field, and suggests strongly that additional research is needed in CKD–MBD
  • All of us working with KDIGO hope that the guidelines developed by KDIGO will in some small way help to fulfill its mission to improve the care and outcomes of patients with kidney disease
  • We thank the Work Group members, the Evidence Review Team, and the Kidney Disease: Improving Global Outcomes staff for their tireless efforts

Need more features? Save interactive summary cards to your Scholarcy Library.